{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:32:56Z","timestamp":1793831576812,"version":"4.6.1"},"reference-count":114,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Inflammatory bowel disease (IBD), comprising ulcerative colitis (UC) and Crohn\u2019s disease (CD), is a chronic condition marked by persistent intestinal inflammation of unknown etiology. Disease onset involves genetic predisposition and environmental factors that disrupt the intestinal immune homeostasis. The intestinal microbiome and immune response play pivotal roles in disease progression. Advances in molecular therapies and early interventions have reduced surgery rates; however, colorectal cancer (CRC) remains a significant concern, driven by chronic inflammation. In UC, the risk of UC-associated neoplasia (UCAN) increases with disease duration, while CD patients face elevated risks of small intestine, anal fistula, and anal canal cancers. Endoscopic surveillance is advised for UCAN, but optimal screening intervals remain undefined, and no established guidelines exist for CD-associated cancers. UCAN morphology often complicates detection due to its flat, inflammation-blended appearance, which differs pathologically from sporadic CRC (sCRC). UCAN is frequently surrounded by dysplasia, with p53 mutations evident at the dysplasia stage. IBD-associated gastrointestinal cancers exemplify inflammation-driven carcinogenesis with distinct molecular mechanisms from the adenoma-carcinoma sequence. This review explores the epidemiology, risk factors, clinical and pathological features, current surveillance practices, and molecular pathways underlying inflammation-associated cancers in IBD.<\/jats:p>","DOI":"10.3390\/cells14080567","type":"journal-article","created":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T05:28:07Z","timestamp":1744262887000},"page":"567","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Inflammation-Associated Carcinogenesis in Inflammatory Bowel Disease: Clinical Features and Molecular Mechanisms"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1178-3536","authenticated-orcid":false,"given":"Tadakazu","family":"Hisamatsu","sequence":"first","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo 181-8611, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo 181-8611, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Oguri","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo 181-8611, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1232-5879","authenticated-orcid":false,"given":"Hiromu","family":"Morikubo","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo 181-8611, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo 181-8611, Japan"},{"name":"Department of Gastroenterology and Hepatology, Kyorin University Suginami Hospital, Tokyo 166-0012, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimasa","family":"Hayashi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kyorin University School of Medicine, Tokyo181-8611, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teppei","family":"Omori","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo 181-8611, Japan"},{"name":"Department of Gastroenterology and Hepatology, Kyorin University Suginami Hospital, Tokyo 166-0012, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9590-2370","authenticated-orcid":false,"given":"Minoru","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Kyorin University School of Medicine, Tokyo 181-8611, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"International Organization for the Study of IBD. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/j.cgh.2020.10.039","article-title":"Contemporary Risk of Surgery in Patients with Ulcerative Colitis and Crohn\u2019s Disease: A Meta-Analysis of Population-Based Cohorts","volume":"19","author":"Tsai","year":"2021","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/gut.48.4.526","article-title":"The risk of colorectal cancer in ulcerative colitis: A meta-analysis","volume":"48","author":"Eaden","year":"2001","journal-title":"Gut"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/ajg.2015.65","article-title":"Forty-Year Analysis of Colonoscopic Surveillance Program for Neoplasia in Ulcerative Colitis: An Updated Overview","volume":"110","author":"Choi","year":"2015","journal-title":"Am. J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/den.12955","article-title":"Results of a 36-year surveillance program for ulcerative colitis-associated neoplasia in the Japanese population","volume":"30","author":"Kishikawa","year":"2018","journal-title":"Dig. Endosc."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","article-title":"Declining risk of colorectal cancer in inflammatory bowel disease: An updated meta-analysis of population-based cohort studies","volume":"19","author":"Lutgens","year":"2013","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.cgh.2012.01.010","article-title":"Risk of colorectal cancer in patients with ulcerative colitis: A meta-analysis of population-based cohort studies","volume":"10","author":"Jess","year":"2012","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(19)32545-0","article-title":"Colorectal cancer in ulcerative colitis: A Scandinavian population-based cohort study","volume":"395","author":"Erichsen","year":"2020","journal-title":"Lancet"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJM199011013231802","article-title":"Ulcerative colitis and colorectal cancer. A population-based study","volume":"323","author":"Ekbom","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1111\/j.1572-0241.2005.00287.x","article-title":"Increased risk of intestinal cancer in Crohn\u2019s disease: A meta-analysis of population-based cohort studies","volume":"100","author":"Jess","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/j.1365-2036.2006.02854.x","article-title":"Meta-analysis: Colorectal and small bowel cancer risk in patients with Crohn\u2019s disease","volume":"23","author":"Canavan","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1053\/j.gastro.2022.05.038","article-title":"Risk of Cancer in Inflammatory Bowel Diseases: Umbrella Review and Reanalysis of Meta-analyses","volume":"163","author":"Piovani","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.dld.2013.04.013","article-title":"Small bowel adenocarcinoma: Epidemiology, risk factors, diagnosis and treatment","volume":"46","author":"Aparicio","year":"2014","journal-title":"Dig. Liver Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s11605-010-1402-9","article-title":"Intestinal cancer risk in Crohn\u2019s disease: A meta-analysis","volume":"15","author":"Laukoetter","year":"2011","journal-title":"J. Gastrointest. Surg."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ecco-jcc\/jjac187","article-title":"ECCO Guidelines on Inflammatory Bowel Disease and Malignancies","volume":"17","author":"Gordon","year":"2023","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1136\/gut.35.7.950","article-title":"Similarity of colorectal cancer in Crohn\u2019s disease and ulcerative colitis: Implications for carcinogenesis and prevention","volume":"35","author":"Choi","year":"1994","journal-title":"Gut"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.cgh.2005.12.035","article-title":"Colorectal cancer prognosis among patients with inflammatory bowel disease","volume":"4","author":"Delaunoit","year":"2006","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s00535-022-01927-y","article-title":"Clinical features and oncological outcomes of intestinal cancers associated with ulcerative colitis and Crohn\u2019s disease","volume":"58","author":"Noguchi","year":"2023","journal-title":"J. Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/jgh.15229","article-title":"Intestinal cancer in patients with Crohn\u2019s disease: A systematic review and meta-analysis","volume":"36","author":"Uchino","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/ecco-jcc\/jjx010","article-title":"European Crohn\u2019s and Colitis Organisation Topical Review on Transitional Care in Inflammatory Bowel Disease","volume":"11","author":"Aloi","year":"2017","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG Clinical Guideline: Ulcerative Colitis in Adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1053\/j.gastro.2020.12.036","article-title":"Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis","volume":"160","author":"Wijnands","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(00)03612-6","article-title":"Colorectal cancer rates among first-degree relatives of patients with inflammatory bowel disease: A population-based cohort study","volume":"357","author":"Askling","year":"2001","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Farraye, F.A., Odze, R.D., Eaden, J., and Itzkowitz, S.H. (2010). AGA technical review on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease. Gastroenterology, 138, quiz e12\u201313.","DOI":"10.1053\/j.gastro.2009.12.037"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.gastro.2021.10.035","article-title":"Colorectal Cancer in Inflammatory Bowel Disease: Mechanisms and Management","volume":"162","author":"Shah","year":"2022","journal-title":"Gastroenterology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.cgh.2018.01.023","article-title":"High Risk of Advanced Colorectal Neoplasia in Patients With Primary Sclerosing Cholangitis Associated With Inflammatory Bowel Disease","volume":"16","author":"Shah","year":"2018","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders","volume":"11","author":"Magro","year":"2017","journal-title":"J. Crohn\u2019s Colitis"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/1097-0142(20010215)91:4<854::AID-CNCR1073>3.0.CO;2-Z","article-title":"Cancer risk in patients with inflammatory bowel disease: A population-based study","volume":"91","author":"Bernstein","year":"2001","journal-title":"Cancer"},{"key":"ref_29","first-page":"297","article-title":"Inflammatory bowel disease and risk of small bowel cancer: A binational population-based cohort study from Denmark and Sweden","volume":"70","author":"Axelrad","year":"2021","journal-title":"Gut"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"483","DOI":"10.14309\/ajg.0000000000000117","article-title":"Surveillance Colonoscopy for Ulcerative Colitis-Associated Colorectal Cancer Offers Better Overall Survival in Real-World Surgically Resected Cases","volume":"114","author":"Hata","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1136\/gut.2003.038505","article-title":"Cancer surveillance in longstanding ulcerative colitis: Endoscopic appearances help predict cancer risk","volume":"53","author":"Rutter","year":"2004","journal-title":"Gut"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s13402-010-0006-4","article-title":"Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: A case-control study","volume":"34","author":"Gerrits","year":"2011","journal-title":"Cell. Oncol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1056\/NEJMra1403718","article-title":"Cancers complicating inflammatory bowel disease","volume":"372","author":"Beaugerie","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.cgh.2020.02.009","article-title":"Predicting, Preventing, and Managing Treatment-Related Complications in Patients With Inflammatory Bowel Diseases","volume":"18","author":"Beaugerie","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1111\/j.1572-0241.2005.41442.x","article-title":"Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: A systematic review and metaanalysis of observational studies","volume":"100","author":"Velayos","year":"2005","journal-title":"Am. J. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","article-title":"British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults","volume":"68","author":"Lamb","year":"2019","journal-title":"Gut."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.gie.2014.12.009","article-title":"SCENIC international consensus statement on surveillance and management of dysplasia in inflammatory bowel disease","volume":"81","author":"Laine","year":"2015","journal-title":"Gastrointest. Endosc."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.gie.2016.11.013","article-title":"Endoscopic morphologic features of ulcerative colitis-associated dysplasia classified according to the SCENIC consensus statement","volume":"85","author":"Sugimoto","year":"2017","journal-title":"Gastrointest. Endosc."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ibd.20267","article-title":"Endoscopic and chromoendoscopic atlas featuring dysplastic lesions in surveillance colonoscopy for patients with long-standing ulcerative colitis","volume":"14","author":"Matsumoto","year":"2008","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/den.12992","article-title":"Linked color imaging identified ulcerative colitis-associated colorectal cancer: A case report","volume":"30","author":"Hisamatsu","year":"2018","journal-title":"Dig. Endosc."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"E1183","DOI":"10.1055\/s-0042-116488","article-title":"Clinical usefulness of narrow band imaging magnifying colonoscopy for assessing ulcerative colitis-associated cancer\/dysplasia","volume":"4","author":"Nishiyama","year":"2016","journal-title":"Endosc. Int. Open"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/den.12644","article-title":"Narrow-band imaging (NBI) magnifying endoscopic classification of colorectal tumors proposed by the Japan NBI Expert Team","volume":"28","author":"Sano","year":"2016","journal-title":"Dig. Endosc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/den.13382","article-title":"Clinical usefulness of magnifying colonoscopy for the diagnosis of ulcerative colitis-associated neoplasia","volume":"31","author":"Kawasaki","year":"2019","journal-title":"Dig. Endosc."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/den.13964","article-title":"Combined endocytoscopy with pit pattern diagnosis in ulcerative colitis-associated neoplasia: Pilot study","volume":"34","author":"Kudo","year":"2022","journal-title":"Dig. Endosc."},{"key":"ref_45","unstructured":"WHO Classification of Tumors Ediotorial Board (2019). Digestive System Tumours, WHO Classification of Tumours, International Agency for Research on Cancer. [5th ed.]."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Lu, X., Yu, Y., and Tan, S. (2017). p53 expression in patients with ulcerative colitis\u2013associated with dysplasia and carcinoma: A systematic meta-analysis. BMC Gastroenterol., 17.","DOI":"10.1186\/s12876-017-0665-y"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/mp.51.6.327","article-title":"Ki-67: A useful marker for the evaluation of dysplasia in ulcerative colitis","volume":"51","author":"Andersen","year":"1998","journal-title":"Mol. Pathol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0046-8177(83)80175-0","article-title":"Dysplasia in inflammatory bowel disease: Standardized classification with provisional clinical applications","volume":"14","author":"Riddell","year":"1983","journal-title":"Hum. Pathol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/den.13482","article-title":"Intramucosal poorly differentiated and signet-ring cell components in patients with ulcerative colitis-associated high-grade dysplasia","volume":"31","author":"Sugimoto","year":"2019","journal-title":"Dig. Endosc."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.dld.2019.05.003","article-title":"Difference in the clinical characteristic and prognosis of colitis-associated cancer and sporadic neoplasia in ulcerative colitis patients","volume":"51","author":"Mutaguchi","year":"2019","journal-title":"Dig. Liver Dis."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00535-018-1439-1","article-title":"Evidence-based clinical practice guidelines for inflammatory bowel disease","volume":"53","author":"Matsuoka","year":"2018","journal-title":"J. Gastroenterol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1053\/j.gastro.2016.08.002","article-title":"Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer","volume":"151","author":"Watanabe","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_53","first-page":"616","article-title":"Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?","volume":"67","author":"Moussata","year":"2018","journal-title":"Gut"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/j.gastro.2021.05.063","article-title":"AGA Clinical Practice Update on Endoscopic Surveillance and Management of Colorectal Dysplasia in Inflammatory Bowel Diseases: Expert Review","volume":"161","author":"Murthy","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1053\/j.gastro.2005.12.035","article-title":"Thirty-year analysis of a colonoscopic surveillance program for neoplasia in ulcerative colitis","volume":"130","author":"Rutter","year":"2006","journal-title":"Gastroenterology"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1007\/s10620-017-4772-y","article-title":"Chromoendoscopy, Narrow-Band Imaging or White Light Endoscopy for Neoplasia Detection in Inflammatory Bowel Diseases","volume":"62","author":"Katz","year":"2017","journal-title":"Dig. Dis. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1016\/j.cgh.2020.04.049","article-title":"High-Definition Chromoendoscopy Superior to High-Definition White-Light Endoscopy in Surveillance of Inflammatory Bowel Diseases in a Randomized Trial","volume":"18","author":"Alexandersson","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.14309\/ajg.0000000000000341","article-title":"High-Definition Chromoendoscopy Versus High-Definition White Light Colonoscopy for Neoplasia Surveillance in Ulcerative Colitis: A Randomized Controlled Trial","volume":"114","author":"Yang","year":"2019","journal-title":"Am. J. Gastroenterol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.gie.2019.04.219","article-title":"Meta-analysis of dye-based chromoendoscopy compared with standard- and high-definition white-light endoscopy in patients with inflammatory bowel disease at increased risk of colon cancer","volume":"90","author":"Feuerstein","year":"2019","journal-title":"Gastrointest. Endosc."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"E578","DOI":"10.1055\/a-1120-8376","article-title":"Surveillance in inflammatory bowel disease: Is chromoendoscopy the only way to go? A systematic review and meta-analysis of randomized clinical trials","volume":"8","author":"Resende","year":"2020","journal-title":"Endosc. Int. Open"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4253\/wjge.v12.i5.159","article-title":"Efficacy of various endoscopic modalities in detecting dysplasia in ulcerative colitis: A systematic review and network meta-analysis","volume":"12","author":"Gondal","year":"2020","journal-title":"World J. Gastrointest. Endosc."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/ibd\/izaa011","article-title":"Meta-analysis of Virtual-based Chromoendoscopy Compared With Dye-spraying Chromoendoscopy Standard and High-definition White Light Endoscopy in Patients With Inflammatory Bowel Disease at Increased Risk of Colon Cancer","volume":"26","author":"Chen","year":"2020","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_63","first-page":"2972","article-title":"Surveillance colonoscopy with pancolonic narrow band imaging observation in patients with ulcerative colitis","volume":"62","author":"Watanabe","year":"2020","journal-title":"Gastroenterol. Endosc."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.gie.2022.02.011","article-title":"Texture and color enhancement imaging in combination with indigo carmine dye spraying to highlight the border of flat ulcerative colitis-associated neoplasia","volume":"95","author":"Takabayashi","year":"2022","journal-title":"Gastrointest. Endosc."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cell.2010.01.025","article-title":"Immunity, inflammation, and cancer","volume":"140","author":"Grivennikov","year":"2010","journal-title":"Cell"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1053\/j.gastro.2011.01.057","article-title":"Intestinal inflammation and cancer","volume":"140","author":"Ullman","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_67","first-page":"560","article-title":"Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis","volume":"118","author":"Popivanova","year":"2008","journal-title":"J. Clin. Investig."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.4049\/jimmunol.171.11.6164","article-title":"Proinflammatory cytokines disrupt epithelial barrier function by apoptosis-independent mechanisms","volume":"171","author":"Bruewer","year":"2003","journal-title":"J. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ccr.2009.01.001","article-title":"IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer","volume":"15","author":"Grivennikov","year":"2009","journal-title":"Cancer Cell"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/carcin\/bgs106","article-title":"Role of IL-17A in the development of colitis-associated cancer","volume":"33","author":"Hyun","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cytogfr.2018.12.002","article-title":"IL-23 in inflammatory bowel diseases and colon cancer","volume":"45","author":"Neurath","year":"2019","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/cac2.12295","article-title":"Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy","volume":"42","author":"Bhat","year":"2022","journal-title":"Cancer Commun."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Miyazaki, Y., Nakamura, T., Takenouchi, S., Hayashi, A., Omori, K., and Murata, T. (2021). Urinary 8-iso PGF2\u03b1 and 2,3-dinor-8-iso PGF2\u03b1 can be indexes of colitis-associated colorectal cancer in mice. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0245292"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1158\/0008-5472.CAN-09-3166","article-title":"Matrix metalloproteinase-9 functions as a tumor suppressor in colitis-associated cancer","volume":"70","author":"Garg","year":"2010","journal-title":"Cancer Res."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"22274","DOI":"10.1074\/jbc.M109.020941","article-title":"Functional cross-talk between beta-catenin and NFkappaB signaling pathways in colonic crypts of mice in response to progastrin","volume":"284","author":"Umar","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/emboj.2008.105","article-title":"Activated macrophages promote Wnt signalling through tumour necrosis factor-alpha in gastric tumour cells","volume":"27","author":"Oguma","year":"2008","journal-title":"EMBO J."},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Kobayashi, K., Tomita, H., Shimizu, M., Tanaka, T., Suzui, N., Miyazaki, T., and Hara, A. (2017). p53 Expression as a Diagnostic Biomarker in Ulcerative Colitis-Associated Cancer. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18061284"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1053\/j.gastro.2015.12.036","article-title":"Whole-Exome Sequencing Analyses of Inflammatory Bowel Disease-Associated Colorectal Cancers","volume":"150","author":"Robles","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1053\/j.gastro.2016.04.001","article-title":"Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease","volume":"151","author":"Yaeger","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"22175","DOI":"10.18632\/oncotarget.14549","article-title":"KRAS and TP53 mutations in inflammatory bowel disease-associated colorectal cancer: A meta-analysis","volume":"8","author":"Du","year":"2017","journal-title":"Oncotarget"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.gtc.2006.07.002","article-title":"Molecular biology of dysplasia and cancer in inflammatory bowel disease","volume":"35","author":"Itzkowitz","year":"2006","journal-title":"Gastroenterol. Clin. N. Am."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/0016-5085(92)91185-7","article-title":"DNA aneuploidy in colonic biopsies predicts future development of dysplasia in ulcerative colitis","volume":"103","author":"Rubin","year":"1992","journal-title":"Gastroenterology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.cell.2020.06.036","article-title":"Somatic Evolution in Non-neoplastic IBD-Affected Colon","volume":"182","author":"Olafsson","year":"2020","journal-title":"Cell"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"C148","DOI":"10.1152\/ajpcell.00422.2001","article-title":"Oxidative stress inactivates the human DNA mismatch repair system","volume":"283","author":"Chang","year":"2002","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1440-1746.2005.03803.x","article-title":"Clinical significance of microsatellite instability in the inflamed mucosa for the prediction of colonic neoplasms in patients with ulcerative colitis","volume":"20","author":"Tahara","year":"2005","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"10322","DOI":"10.18632\/oncotarget.7188","article-title":"Aberrant gene methylation in non-neoplastic mucosa as a predictive marker of ulcerative colitis-associated CRC","volume":"7","author":"Scarpa","year":"2016","journal-title":"Oncotarget"},{"key":"ref_87","first-page":"4864","article-title":"Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1","volume":"60","author":"Fleisher","year":"2000","journal-title":"Cancer Res."},{"key":"ref_88","first-page":"5193","article-title":"Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses","volume":"61","author":"Meyers","year":"2001","journal-title":"Cancer Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1136\/gut.2004.062059","article-title":"Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis","volume":"54","author":"Fujii","year":"2005","journal-title":"Gut"},{"key":"ref_90","first-page":"3573","article-title":"Accelerated age-related CpG island methylation in ulcerative colitis","volume":"61","author":"Issa","year":"2001","journal-title":"Cancer Res."},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Cancer Genome Atlas Network (2012). Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487, 330\u2013337.","DOI":"10.1038\/nature11252"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"969","DOI":"10.18632\/oncotarget.22867","article-title":"Genomic landscape of colitis-associated cancer indicates the impact of chronic inflammation and its stratification by mutations in the Wnt signaling","volume":"9","author":"Fujita","year":"2018","journal-title":"Oncotarget"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.gastro.2021.04.042","article-title":"Genetic and Epigenetic Characteristics of Inflammatory Bowel Disease-Associated Colorectal Cancer","volume":"161","author":"Taira","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s10555-017-9726-5","article-title":"Mutations of key driver genes in colorectal cancer progression and metastasis","volume":"37","author":"Huang","year":"2018","journal-title":"Cancer Metastasis Rev."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","article-title":"Gut microbiota-derived metabolites as key actors in inflammatory bowel disease","volume":"17","author":"Lavelle","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Lee, J.G., Lee, Y.R., Lee, A.R., Park, C.H., Han, D.S., and Eun, C.S. (2021). Role of the global gut microbial community in the development of colitis-associated cancer in a murine model. Biomed. Pharmacother., 135.","DOI":"10.1016\/j.biopha.2020.111206"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1053\/j.gastro.2016.10.012","article-title":"Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches","volume":"152","author":"Sartor","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_98","first-page":"285","article-title":"Whole exome sequencing analyses reveal gene-microbiota interactions in the context of IBD","volume":"70","author":"Hu","year":"2021","journal-title":"Gut"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1053\/j.gastro.2018.07.038","article-title":"The Potential Role of Exercise and Nutrition in Harnessing the Immune System to Improve Colorectal Cancer Survival","volume":"155","author":"Song","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mam.2019.05.001","article-title":"Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential","volume":"69","author":"Saus","year":"2019","journal-title":"Mol. Asp. Med."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.chom.2013.07.007","article-title":"Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment","volume":"14","author":"Kostic","year":"2013","journal-title":"Cell Host Microbe"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/ibd.21606","article-title":"Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host","volume":"17","author":"Strauss","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"11537","DOI":"10.1073\/pnas.1001261107","article-title":"Escherichia coli induces DNA damage in vivo and triggers genomic instability in mammalian cells","volume":"107","author":"Petit","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Buc, E., Dubois, D., Sauvanet, P., Raisch, J., Delmas, J., Darfeuille-Michaud, A., Pezet, D., and Bonnet, R. (2013). High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056964"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.chom.2013.07.012","article-title":"Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin\/\u03b2-catenin signaling via its FadA adhesin","volume":"14","author":"Rubinstein","year":"2013","journal-title":"Cell Host Microbe"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.1224820","article-title":"Intestinal inflammation targets cancer-inducing activity of the microbiota","volume":"338","author":"Arthur","year":"2012","journal-title":"Science"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.1127059","article-title":"Escherichia coli induces DNA double-strand breaks in eukaryotic cells","volume":"313","author":"Homburg","year":"2006","journal-title":"Science"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"e02393-17","DOI":"10.1128\/mBio.02393-17","article-title":"The Colibactin Genotoxin Generates DNA Interstrand Cross-Links in Infected Cells","volume":"9","author":"Vignard","year":"2018","journal-title":"mBio"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1349-7006.2003.tb01386.x","article-title":"A novel inflammation-related mouse colon carcinogenesis model induced by azoxymethane and dextran sodium sulfate","volume":"94","author":"Tanaka","year":"2003","journal-title":"Cancer Sci."},{"key":"ref_110","doi-asserted-by":"crossref","unstructured":"Modesto, R., Estarreja, J., Silva, I., Rocha, J., Pinto, R., and Mateus, V. (2022). Induced Colitis-Associated Cancer Models in Rodents for Pharmacological Modulation: A Systematic Review. J. Clin. Med., 11.","DOI":"10.3390\/jcm11102739"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/carcin\/bgs183","article-title":"Dynamic activation of the key pathways: Linking colitis to colorectal cancer in a mouse model","volume":"33","author":"Tang","year":"2012","journal-title":"Carcinogenesis"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s10620-022-07774-4","article-title":"Establishment of a Novel Colitis-Associated Cancer Mouse Model Showing Flat Invasive Neoplasia","volume":"68","author":"Uragami","year":"2023","journal-title":"Dig. Dis. Sci."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41586-019-1844-5","article-title":"Somatic inflammatory gene mutations in human ulcerative colitis epithelium","volume":"577","author":"Nanki","year":"2020","journal-title":"Nature"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41586-019-1856-1","article-title":"Frequent mutations that converge on the NFKBIZ pathway in ulcerative","volume":"577","author":"Kakiuchi","year":"2020","journal-title":"Nature"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/8\/567\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T17:11:49Z","timestamp":1760029909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/14\/8\/567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":114,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["cells14080567"],"URL":"https:\/\/doi.org\/10.3390\/cells14080567","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]}}}